Modulation of Gut Microbial Biomarkers and Metabolites in Cancer Management by Tea Compounds

Area of Science:

• Oncology and Microbiology
• Natural Product Chemistry
• Metabolomics

Background:

• Cancer poses a significant global health and economic burden, with high drug costs limiting patient access.
• Microbiome-targeted therapies are emerging as promising, affordable cancer treatment strategies.
• Dietary compounds, like tea, can modulate gut microbiota and possess anti-cancer properties.

Purpose of the Study:

• To comprehensively review the effects of tea compounds on gut microbiota in cancer.
• To explore the link between modulated gut bacteria, their metabolites, and cancer intervention.
• To summarize the mechanisms underlying tea's impact on cancer via gut microbiota modulation.

Main Methods:

• Literature review of studies investigating tea compounds, gut microbiota, and cancer.
• Analysis of research on the anti-cancer and microbiome-modulating effects of various tea types.
• Synthesis of data on bacterial metabolite changes and their role in cancer treatment.

Main Results:

• Tea compounds demonstrate significant potential in modulating gut microbiota composition.
• Specific bacterial shifts induced by tea are linked to anti-cancer activities.
• Metabolite profiles are reshaped by tea compounds, influencing cancer progression and treatment.

Conclusions:

• Tea compounds offer a promising avenue for microbiome-targeted cancer therapy.
• Understanding the interplay between tea, gut microbiota, and metabolites can optimize cancer treatment strategies.
• Further research into tea's mechanistic effects can lead to more accessible and affordable cancer interventions.